Umbilical Cord Milking for Neonates With Hypoxic Ischemic Encephalopathy
NCT ID: NCT02287077
Last Updated: 2017-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2014-12-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate cord clamping
At birth, neonate will be held at the level of placenta and umbilical cord will be clamped immediately (standard of care for depressed neonates).
No interventions assigned to this group
Umbilical cord milking
At birth, neonate will be held below the level of placenta and umbilical cord will be milked 3 times before clamping the cord.
Umbilical Cord Milking
At birth, neonate will be held below the level of placenta and umbilical cord will be milked 3 times before clamping the cord.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Umbilical Cord Milking
At birth, neonate will be held below the level of placenta and umbilical cord will be milked 3 times before clamping the cord.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Depressed at birth
Exclusion Criteria
* Chromosomal abnormalities
* Major congenital malformations
1 Minute
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lata Mangeshkar Hospital, NKP Salve Institute of Medical Sciences, Nagpur, India
UNKNOWN
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lata Mangeshkar Hospital and NKP Salve Institute of Medical Sciences
Nagpur, MS, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14D.522
Identifier Type: -
Identifier Source: org_study_id